PYC Therapeutics Correlations

Stocks . Australia . 
Stock . PYC Therapeutics
PYC Stock   1.40  0.05  3.45%   
The current 90-days correlation between PYC Therapeutics and FSA Group is -0.08 (i.e., Good diversification). The correlation of PYC Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

PYC Therapeutics Correlation With Market

Good diversification

The correlation between PYC Therapeutics and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding PYC Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to PYC Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PYC Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PYC Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PYC Therapeutics to buy it.

Moving together with PYC Stock

  0.73AN3PJ ANZ Group HoldingsPairCorr
  0.61ANZ Australia and NewPairCorr
  0.61AN3PI ANZ Group HoldingsPairCorr
  0.61SFR Sandfire ResourcesPairCorr

Moving against PYC Stock

  0.73BVS Bravura SolutionsPairCorr
  0.71AHF Australian Dairy FarmsPairCorr
  0.68BIS Bisalloy Steel GroupPairCorr
  0.63HOR Horseshoe MetalsPairCorr
  0.56AME Alto MetalsPairCorr
  0.51IAG Insurance AustraliaPairCorr
  0.43CVV Caravel MineralsPairCorr
  0.34ATM Aneka Tambang TbkPairCorr
  0.33BEN Bendigo And AdelaidePairCorr
  0.31CBA Commonwealth BankPairCorr
  0.79MME MoneyMePairCorr
  0.58ST1 Spirit Telecom SplitPairCorr
  0.54JBH JB Hi FiPairCorr
  0.45ABA Auswide BankPairCorr
  0.44BPT Beach EnergyPairCorr
  0.44SQ2 Block IncPairCorr
  0.42IMR Imricor Medical SystemsPairCorr
  0.4ORG Origin EnergyPairCorr
  0.4AHC Austco HealthcarePairCorr
  0.39GNM Great Northern MineralsPairCorr
  0.38GMD Genesis MineralsPairCorr
  0.36KKC Kkr Credit IncomePairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
PME
+ 0.94
SQ2
XRO
+ 0.93
SQ2
XRO
+ 0.88
PME
SQ2
+ 0.86
REA
XRO
+ 0.85
REA
XRO
+ 0.79
COH
  
High negative correlations   
XRO
- 0.88
FSA
SQ2
- 0.87
FSA
PME
- 0.86
FSA
REA
- 0.72
FSA
COH
- 0.64
FSA
LNW
- 0.35
FSA

Risk-Adjusted Indicators

There is a big difference between PYC Stock performing well and PYC Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze PYC Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in PYC Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Pair Correlation Now

   

Pair Correlation

Compare performance and examine fundamental relationship between any two equity instruments
All  Next Launch Module

PYC Therapeutics Corporate Management

Elected by the shareholders, the PYC Therapeutics' board of directors comprises two types of representatives: PYC Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PYC. The board's role is to monitor PYC Therapeutics' management team and ensure that shareholders' interests are well served. PYC Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PYC Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
MD MBAChief OperationsProfile
Glenn NoronhaChief OfficerProfile
BComm BComCompany SecretaryProfile
Pr FletcherChief OfficerProfile
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY